Evidence map›Paper›PMID 33195496›Full record

ArticleFrontiers in veterinary science2020

Bovine Dendritic Cell Activation, T Cell Proliferation and Antibody Responses to Foot-And-Mouth Disease, Is Similar With Inactivated Virus and Virus Like Particles.

Valeria Quattrocchi, Juan Bidart, Ana Clara Mignaqui, Vanesa Ruiz, Alejandra Ferella, Cecilia Langellotti, Mariela Gammella, Sergio Ferraris, Jorge Carrillo, Andres Wigdorovitz and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in veterinary science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Foot-and-mouth disease in Asia.Virus research · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Valeria QuattrocchiIVIT, INTA, CONICET, Buenos Aires, Argentina.
Juan BidartIVIT, INTA, CONICET, Buenos Aires, Argentina.
Ana Clara MignaquiIFAB, INTA, CONICET, San Carlos de Bariloche, Argentina.
Vanesa RuizIVIT, INTA, CONICET, Buenos Aires, Argentina.
Alejandra FerellaIVIT, INTA, CONICET, Buenos Aires, Argentina.
Cecilia LangellottiIVIT, INTA, CONICET, Buenos Aires, Argentina.
Mariela GammellaIVIT, INTA, CONICET, Buenos Aires, Argentina.
Sergio FerrarisCentro de Ciencias Veterinarias, Universidad Maimónides, Buenos Aires, Argentina.
Jorge CarrilloCIA - INTA Castelar, Buenos Aires, Argentina.
Andres WigdorovitzIVIT, INTA, CONICET, Buenos Aires, Argentina.
Yves DurocherHuman Health Therapeutics Research Center, National Research Council Canada, Montreal, QC, Canada.
Sabrina Beatriz CardilloBiogénesis-Bagó S.A., Buenos Aires, Argentina.
Bryan CharlestonBBSRC National Virology Centre, The Pirbright Institute, Woking, United Kingdom.
Patricia Inés ZamoranoIVIT, INTA, CONICET, Buenos Aires, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARNational Research Council Canada · CAThe Pirbright Institute · GBUniversidad Maimónides · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Foot-and-mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals that causes severe economic losses in the livestock industry. Currently available vaccines are based on the inactivated FMD virus (FMDV). Although inactivated vaccines have been effective in controlling the disease, they have some disadvantages. Because of these disadvantages, investigations are being made to produce vaccines in low containment facilities. The use of recombinant empty capsids (also referred as Virus Like Particles, VLPs) has been reported to be a promising candidate as a subunit vaccine because it avoids the use of virus in the vaccine production and conserves the conformational epitopes of the virus. Mignaqui and collaborators have produced recombinant FMDV empty capsids from serotype A/ARG/2001 using a scalable technology in mammalian cells that elicited a protective immunity against viral challenge in a mouse model. However, further evaluation of the immune response elicited by these VLPs in cattle is required. In the present work we compare the effect that VLPs or inactivated FMDV has on bovine dendritic cells and the humoral response elicited in cattle after a single vaccination.

Indexed as

A/ARG/2001bovinedendritic cellsempty capsidsFMDV

Identifiers

PMID33195496
PMCPMC7554300
OpenAlexW3091426853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.